---
pmid: '23364696'
title: Identification of a candidate therapeutic autophagy-inducing peptide.
authors:
- Shoji-Kawata S
- Sumpter R
- Leveno M
- Campbell GR
- Zou Z
- Kinch L
- Wilkins AD
- Sun Q
- Pallauf K
- MacDuff D
- Huerta C
- Virgin HW
- Helms JB
- Eerland R
- Tooze SA
- Xavier R
- Lenschow DJ
- Yamamoto A
- King D
- Lichtarge O
- Grishin NV
- Spector SA
- Kaloyanova DV
- Levine B
journal: Nature
year: '2013'
full_text_available: false
pmcid: PMC3788641
doi: 10.1038/nature11866
---

# Identification of a candidate therapeutic autophagy-inducing peptide.
**Authors:** Shoji-Kawata S, Sumpter R, Leveno M, Campbell GR, Zou Z, Kinch L, Wilkins AD, Sun Q, Pallauf K, MacDuff D, Huerta C, Virgin HW, Helms JB, Eerland R, Tooze SA, Xavier R, Lenschow DJ, Yamamoto A, King D, Lichtarge O, Grishin NV, Spector SA, Kaloyanova DV, Levine B
**Journal:** Nature (2013)
**DOI:** [10.1038/nature11866](https://doi.org/10.1038/nature11866)
**PMC:** [PMC3788641](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3788641/)

## Abstract

1. Nature. 2013 Feb 14;494(7436):201-6. doi: 10.1038/nature11866. Epub 2013 Jan
30.

Identification of a candidate therapeutic autophagy-inducing peptide.

Shoji-Kawata S(1), Sumpter R, Leveno M, Campbell GR, Zou Z, Kinch L, Wilkins AD, 
Sun Q, Pallauf K, MacDuff D, Huerta C, Virgin HW, Helms JB, Eerland R, Tooze SA, 
Xavier R, Lenschow DJ, Yamamoto A, King D, Lichtarge O, Grishin NV, Spector SA, 
Kaloyanova DV, Levine B.

Author information:
(1)Department of Internal Medicine, UT Southwestern Medical Center, Dallas, 
Texas 75390, USA.

Comment in
    Nature. 2013 Feb 14;494(7436):181-2. doi: 10.1038/nature11947.
    Nat Rev Drug Discov. 2013 Mar;12(3):190. doi: 10.1038/nrd3970.
    Rejuvenation Res. 2014 Aug;17(4):382-4. doi: 10.1089/rej.2014.1585.

The lysosomal degradation pathway of autophagy has a crucial role in defence 
against infection, neurodegenerative disorders, cancer and ageing. Accordingly, 
agents that induce autophagy may have broad therapeutic applications. One 
approach to developing such agents is to exploit autophagy manipulation 
strategies used by microbial virulence factors. Here we show that a peptide, 
Tat-beclin 1-derived from a region of the autophagy protein, beclin 1, which 
binds human immunodeficiency virus (HIV)-1 Nef-is a potent inducer of autophagy, 
and interacts with a newly identified negative regulator of autophagy, GAPR-1 
(also called GLIPR2). Tat-beclin 1 decreases the accumulation of polyglutamine 
expansion protein aggregates and the replication of several pathogens (including 
HIV-1) in vitro, and reduces mortality in mice infected with chikungunya or West 
Nile virus. Thus, through the characterization of a domain of beclin 1 that 
interacts with HIV-1 Nef, we have developed an autophagy-inducing peptide that 
has potential efficacy in the treatment of human diseases.

DOI: 10.1038/nature11866
PMCID: PMC3788641
PMID: 23364696 [Indexed for MEDLINE]

Conflict of interest statement: The authors declare no competing financial 
interests.
